Risk of thiazide-induced hyponatremia in patients with hypertension

American Journal of Medicine

Volumn 124, Issue 11, 2011, Pages 1064-1072

  Leung, Alexander A ^a   Wright, Adam ^a   Pazo, Valeria ^a   Karson, Andrew ^b   Bates, David W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Hypertension; Hyponatremia; Incidence; Thiazide diuretics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLOROTHIAZIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; INDAPAMIDE; METHYCLOTHIAZIDE; METOLAZONE; THIAZIDE DIURETIC AGENT; TRICHLORMETHIAZIDE;

ADULT; AGED; ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPONATREMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THIAZIDE INDUCED HYPONATREMIA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPONATREMIA; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; NUMBERS NEEDED TO TREAT; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 80055000505     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.06.031     Document Type: Article

References (43)

1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
2. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
3. J.A. Whitworth 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J Hypertens 21 2003 1983 1992 (Pubitemid 38296854)
4. M.E. Ernst, and M. Moser Use of diuretics in patients with hypertension N Engl J Med 361 2009 2153 2164
5. National Collaborating Centre for Chronic Conditions (UK) Hypertension: management in adults in primary care: pharmacological update National Institute for Health and Clinical Excellence Clinical Guidelines, No 34 2006 Royal College of Physicians London
6. A. Boscoe, C. Paramore, and J.G. Verbalis Cost of illness of hyponatremia in the United States Cost Eff Resour Alloc 4 2006 10
7. M.A. Callahan, H.T. Do, D.W. Caplan, and K. Yoon-Flannery Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study Postgrad Med 121 2009 186 191
8. A.M. Shea, B.G. Hammill, L.H. Curtis, L.A. Szczech, and K.A. Schulman Medical costs of abnormal serum sodium levels J Am Soc Nephrol 19 2008 764 770
9. M.D. Zilberberg, A. Exuzides, and J. Spalding Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients Curr Med Res Opin 24 2008 1601 1608 (Pubitemid 351929058)
10. C.M. Byatt, P.H. Millard, and G.E. Levin Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions J R Soc Med 83 1990 704 708 (Pubitemid 20361564)
11. K.M. Chow, C.C. Szeto, T.Y. Wong, C.B. Leung, and P.K. Li Risk factors for thiazide-induced hyponatraemia QJM 96 2003 911 917 (Pubitemid 37540665)
12. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
13. D.N. Juurlink, M.M. Mamdani, and D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551 (Pubitemid 39025171)
14. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
15. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920 (Pubitemid 37323253)
16. K.L. Movig, H.G. Leufkens, A.W. Lenderink, and A.C. Egberts Validity of hospital discharge International Classification of Diseases (ICD) codes for identifying patients with hyponatremia J Clin Epidemiol 56 2003 530 535 (Pubitemid 36842910)
17. A.M. Shea, L.H. Curtis, L.A. Szczech, and K.A. Schulman Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States BMC Nephrol 9 2008 5
18. S.S. Waikar, D.B. Mount, and G.C. Curhan Mortality after hospitalization with mild, moderate, and severe hyponatremia Am J Med 122 2009 857 865
19. H. Quan, V. Sundararajan, and P. Halfon Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139 (Pubitemid 41587600)
20. M.S. Pepe, and M. Mori Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12 1993 737 751 (Pubitemid 23134304)
21. D.G. Altman, and P.K. Andersen Calculating the number needed to treat for trials where the outcome is time to an event BMJ 319 1999 1492 1495
22. S. Suissa Calculation of number needed to treat N Engl J Med 361 2009 424 425
23. M. Sonnenblick, Y. Friedlander, and A.J. Rosin Diuretic-induced severe hyponatremia Review and analysis of 129 reported patients Chest 103 1993 601 606 (Pubitemid 23070771)
24. R.C. Hawkins Age and gender as risk factors for hyponatremia and hypernatremia Clin Chim Acta 337 2003 169 172 (Pubitemid 37329815)
25. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
26. F. Turnbull Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535 (Pubitemid 37410190)
27. F. Turnbull, B. Neal, and T. Ninomiya Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials BMJ 336 2008 1121 1123 (Pubitemid 351731743)
28. F. Turnbull, M. Woodward, and B. Neal Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials Eur Heart J 29 2008 2669 2680
29. J.M. Wright, and V.M. Musini First-line drugs for hypertension Cochrane Database Syst Rev 3 2009 CD001841
30. Medical Research Council Working Party MRC trial of treatment of mild hypertension: principal results Br Med J (Clin Res Ed) 291 1985 97 104
31. MRC Working Party Medical Research Council trial of treatment of hypertension in older adults: principal results BMJ 304 1992 405 412
32. L. Wilhelmsen, G. Berglund, and D. Elmfeldt Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial J Hypertens 5 1987 561 572
33. L.M. Wing, C.M. Reid, and P. Ryan A comparison of outcomes with angiotensin-convertingenzyme inhibitors and diuretics for hypertension in the elderly N Engl J Med 348 2003 583 592 (Pubitemid 36204952)
34. A. Zanchetti, G. Crepaldi, and M.G. Bond Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLISa randomized double-blind trial Stroke 35 2004 2807 2812 (Pubitemid 39565175)
35. N.O. Borhani, M. Mercuri, and P.A. Borhani Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) A randomized controlled trial JAMA 276 1996 785 791 (Pubitemid 26301577)
36. M.J. Brown, C.R. Palmer, and A. Castaigne Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) Lancet 356 2000 366 372 (Pubitemid 30487492)
37. I. Kuwajima, K. Kuramoto, and T. Ogihara Tolerability and safety of a calcium channel blocker in comparison with a diuretic in the treatment of elderly patients with hypertension: secondary analysis of the NICS-EH Hypertens Res 24 2001 475 480 (Pubitemid 33048911)
38. E.A. Rosei, C. Dal Palu, G. Leonetti, B. Magnani, A. Pessina, and A. Zanchetti Clinical results of the Verapamil in Hypertension and Atherosclerosis Study VHAS Investigators J Hypertens 15 1997 1337 1344 (Pubitemid 27453187)
39. A. Sajadieh, Z. Binici, M.R. Mouridsen, O.W. Nielsen, J.F. Hansen, and S.B. Haugaard Mild hyponatremia carries a poor prognosis in community subjects Am J Med 122 2009 679 686
40. A. Upadhyay, B.L. Jaber, and N.E. Madias Epidemiology of hyponatremia Semin Nephrol 29 2009 227 238
41. R. Wald, B.L. Jaber, L.L. Price, A. Upadhyay, and N.E. Madias Impact of hospital-associated hyponatremia on selected outcomes Arch Intern Med 170 2010 294 302
42. G. Decaux Is asymptomatic hyponatremia really asymptomatic? Am J Med 119 2006 S79 S82
43. F. Gankam Kengne, C. Andres, L. Sattar, C. Melot, and G. Decaux Mild hyponatremia and risk of fracture in the ambulatory elderly QJM 101 2008 583 588 (Pubitemid 351912001)